Search bioRxiv⌕ Search

Biology subjects

Slobodyanyuk, M.

Publications and source records attributed to Slobodyanyuk, M..

2 recordsLinked to original sources

Directional integration and pathway enrichment analysis for multi-omics data

Omics techniques generate comprehensive profiles of biomolecules in cells and tissues. However, a holistic understanding of the data requires joint multi-omics analyses that are challenging. Here we present DPM, a data fusion method for combining multiple omics datasets using directionality and significance estimates of genes, transcripts, or proteins. DPM allows users to define how the input datasets are expected to interact directionally, reflecting the initial experimental design or regulatory relationships between the datasets. DPM statistically prioritises genes and pathways that change consistently across the datasets, while penalising those violating the constraints. Joint analyses of transcriptomic, proteomic, DNA methylation, and clinical datasets of cancer samples demonstrate how directional integration identifies genes and pathways modulated across omics datasets, highlights those with inconsistent evidence, and reveals candidate biomarkers with prognostic signals in multiple datasets. DPM is implemented in the ActivePathways method and provides a general framework for testing detailed hypotheses in multi-omics data.

bioinformatics↗

Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes

Mutational signatures represent a footprint of tumor evolution and its endogenous and exogenous mutational processes. However, their functional impact on the proteome remains incompletely understood. We analysed the protein-coding impact of single base substitution signatures in 12,341 cancer genomes from 18 cancer types. Stop-gain mutations (SGMs) were strongly enriched in the signatures of tobacco smoking, APOBEC cytidine deaminases, and reactive oxygen species. These mutational processes affect specific trinucleotide contexts to substitute serine and glutamic acid residues with stop codons. SGMs are enriched in cancer hallmark pathways and tumor suppressors such as TP53, FAT1, and APC. Tobacco-driven SGMs in lung cancer correlate with lifetime smoking history and highlight a preventable determinant of these harmful mutations. Our study exposes SGM expansion as a genetic mechanism by which endogenous and carcinogenic mutational processes contribute to protein loss-of-function, oncogenesis, and tumor heterogeneity, providing potential translational and mechanistic insights.

cancer biology↗